Literature DB >> 21415745

Fertility preservation as a public health issue: an epidemiological perspective.

William Murk1, Emre Seli.   

Abstract

PURPOSE OF REVIEW: Over the past decade, fertility preservation has become an increasingly viable option for patients diagnosed with diseases such as cancer and systemic lupus erythematosus (SLE), whose treatment often results in impaired fertility. This review summarizes current epidemiological trends that have caused cancer-related and SLE-related infertility to be an important and growing public health burden, which may be reduced by improving access to fertility preservation services. RECENT
FINDINGS: In the United States alone, over 130 000 men and women below the age of 45 were afflicted by cancer in 2008. The compromised fertility that will be faced by many of these patients can result in significant psychosocial stress and reduced quality of life, even long after the disease has been successfully treated. Although the use of fertility preservation services may help alleviate this burden, access to these services is often inadequate, because of logistical barriers and a lack of appropriate patient referral by healthcare providers.
SUMMARY: Increases in cancer survival rates and the average age at which a mother will have her first child has put added emphasis on the need for fertility preservation services. Enhanced provider and patient education, as well improved coordination of oncological-reproductive care, may promote patient access to fertility preservation services.

Entities:  

Mesh:

Year:  2011        PMID: 21415745     DOI: 10.1097/GCO.0b013e3283455270

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  7 in total

1.  Fertility Preservation Methods in Breast Cancer.

Authors:  Fedro A Peccatori; Lino Del Pup; Francesca Salvagno; Maurizio Guido; Maria A Sarno; Alberto Revelli; Luisa Delle Piane; Elisabetta Dolfin; Dorella Franchi; Emanuela Molinari; Valentina Immediata; Leonora Chiavari; Alessandra Vucetich; Andrea Borini
Journal:  Breast Care (Basel)       Date:  2012-06-27       Impact factor: 2.860

2.  Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.

Authors:  F Cavagna; A Pontes; M Cavagna; A Dzik; N F Donadio; R Portela; M T Nagai; L H Gebrim
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

Review 3.  A Review of the Oncology Patient's Challenges for Utilizing Fertility Preservation Services.

Authors:  Dina M Flink; Jeanelle Sheeder; Laxmi A Kondapalli
Journal:  J Adolesc Young Adult Oncol       Date:  2016-08-16       Impact factor: 2.223

4.  Characterization of the gonadotropin releasing hormone receptor (GnRHR) expression and activity in the female mouse ovary.

Authors:  Saioa Torrealday; Maria D Lalioti; Ozlem Guzeloglu-Kayisli; Emre Seli
Journal:  Endocrinology       Date:  2013-08-02       Impact factor: 4.736

5.  Multiple approaches for individualized fertility protective therapy in cancer patients.

Authors:  I Demeestere; F Moffa; F Peccatori; C Poirot; E Shalom-Paz
Journal:  Obstet Gynecol Int       Date:  2011-12-29

Review 6.  Fertility preservation and breast cancer: a review.

Authors:  María de Pedro; Borja Otero; Belén Martín
Journal:  Ecancermedicalscience       Date:  2015-02-03

7.  Responses to fertility treatment among patients with cancer: a retrospective cohort study.

Authors:  A V Dolinko; L V Farland; S A Missmer; S S Srouji; C Racowsky; E S Ginsburg
Journal:  Fertil Res Pract       Date:  2018-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.